Lung overexpression of angiostatin aggravates pulmonary hypertension in chronically hypoxic mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 29, Issue 4, 2003, Pages 449-457

  Pascaud, Marie Aude ^b   Griscelli, Frank ^b   Raoul, William ^b   Marcos, Elisabeth ^b   Opolon, Paule ^b   Raffestin, Bernadette ^b   Perricaudet, Michael ^b   Adnot, Serge ^a   Eddahibi, Saadia ^b  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; ANGIOSTATIN; ANGIOSTATIN K3; BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; EXPERIMENTAL MOUSE; EXPRESSION VECTOR; GENE CASSETTE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE PRESSURE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LUNG ENDOTHELIUM; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PLAQUE FORMING CELL; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALIA; CYTOMEGALOVIRUS; VECTORS;

EID: 0141526110     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2002-0120OC     Document Type: Article

References (26)

1. Eddahibi, S., V. Fabre, C. Boni, M. P. Martres, B. Raffestin, M. Hamon, and S. Adnot. 1999. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells: relationship with the mitogenic action of serotonin. Circ. Res. 84:329-336.
2. Kourembanas, S., and M. Bernfield. 1994. Hypoxia and endothelial-smooth muscle cell interactions in the lung. Am. J. Respir. Cell Mol. Biol. 11:373-374.
3. Boussat, S., S. Eddahibi, A. Coste, V. Fataccioli, M. Gouge, B. Housset, S. Adnot, and B. Maitre. 2000. Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:L371-L378.
4. Kourembanas, S., T. Morita, Y. Liu, and H. Christou. 1997. Mechanisms by which oxygen regulates gene expression and cell-cell interaction in the vasculature. Kidney Int. 51:438-443.
5. Christou, H., A. Yoshida, V. Arthur, T. Morita, and S. Kourembanas. 1998. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 18:768-776.
6. Pfeifer, M., F. C. Blumberg, K. Wolf, P. Sandner, D. Elsner, G. A. Riegger, and A. Kurtz. 1998. Vascular remodeling and growth factor gene expression in the rat lung during hypoxia. Respir. Physiol. 111:201-212.
7. Tuder, R. M., B. E. Flook, and N. F. Voelkel. 1995. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia: modulation of gene expression by nitric oxide. J. Clin. Invest. 95:1798-1807.
8. Eddahibi, S., M. Humbert, S. Sediame, C. Chouaid, C. Partovian, B. Maitre, E. Teiger, D. Rideau, G. Simonneau, O. Sitbon, and S. Adnot. 2000. Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension: effect of prostacyclin therapy. Am. J. Respir. Crit. Care Med. 162:1493-1499.
9. Taraseviciene-Stewart, L., Y. Kasahara, L. Alger, P. Hirth, G. Mc Mahon, J. Waltenberger, N. F. Voelkel, and R. M. Tuder. 2001. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J. 15:427-438.
10. Partovian, C., S. Adnot, B. Raffestin, V. Louzier, M. Levame, I. M. Mavier, P. Lemarchand, and S. Eddahibi. 2000. Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats. Am. J. Respir. Cell Mol. Biol. 23:762-771.
11. Brown, K. R., K. M. England, K. L. Goss, J. M. Snyder, and M. J. Acarregui. 2001. VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:L1001-L1010.
12. Barleon, B., S. Sozzani, D. Zhou, H. A. Weich, A. Mantovani, and D. Marme. 1996. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336-3343.
13. Sawano, A., S. Iwai, Y. Sakurai, M. Ito, K. Shitara, T. Nakahata, and M. Shibuya. 2001. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 97:785-791.
14. O'Reilly, M. S., L. Holmgren, Y. Shing, C. Chen, R. A. Rosenthal, M. Moses, W. S. Lane, Y. Cao, E. H. Sage, and J. Folkman. 1994. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328.
15. Griscelli, F., H. Li, A. Bennaceur-Griscelli, J. Soria, P. Opolon, C. Soria, M. Perricaudet, P. Yeh, and H. Lu. 1998. Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc. Natl. Acad. Sci. USA 95:6367-6372.
16. Cao, Y., R. W. Ji, D. Davidson, J. Schaller, D. Marti, S. Sohndel, S. G. McCance, M. S. O'Reilly, M. Llinas, and J. Folkman. 1996. Kringle domains of human angiostatin: characterization of the anti-proliferative activity on endothelial cells. J. Biol. Chem. 271:29461-29467.
17. Eddahibi, S., M. Humbert, E. Fadel, B. Raffestin, M. Darmon, F. Capron, G. Simonneau, P. Dartevelle, M. Hamon, and S. Adnot. 2001. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J. Clin. Invest. 108:1141-1150.
18. Planus, E., S. Galiacy, M. Matthay, V. Laurent, J. Gavrilovic, G. Murphy, C. Clerici, D. Isabey, C. Lafuma, and M. P. d'Ortho. 1999. Role of collagenase in mediating in vitro alveolar epithelial wound repair. J. Cell Sci. 112:243-252.
19. Deindl, E., I. Buschmann, I. E. Hoefer, T. Podzuweit, K. Boengler, S. Vogel, N. van Royen, B. Fernandez, and W. Schaper. 2001. Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ. Res. 89:779-786.
20. Meyrick, B., and L. Reid. 1980. Endothelial and subintimal changes in rat hilar pulmonary artery during recovery from hypoxia: a quantitative ultrastructural study. Lab. Invest. 42:603-615.
21. Kasahara, Y., R. M. Tuder, L. Taraseviciene-Stewart, T. D. Le Cras, S. Abman, P. K. Hirth, J. Waltenberger, and N. F. Voelkel. 2000. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest. 106:1311-1319.
22. O'Reilly, M. S., L. Holmgren, C. Chen, and J. Folkman. 1996. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med. 2:689-692.
23. Cao, Y., A. Chen, S. S. An, R. W. Ji, D. Davidson, and M. Llinas. 1997. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J. Biol. Chem. 272:22924-22928.
24. Meyrick, B., and L. Reid. 1983. Pulmonary hypertension: anatomic and physiologic correlates. Clin. Chest Med. 4:199-217.
25. Claesson-Welsh, L., M. Welsh, N. Ito, B. Anand-Apte, S. Soker, B. Zetter, M. O'Reilly, and J. Folkman. 1998. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc. Natl. Acad. Sci. USA. 95:5579-5583.
26. Lucas, R., L. Holmgren, I. Garcia, B. Jimenez, S. J. Mandriota, F. Borlat, B. K. L. Sim, Z. Wu, G. E. Grau, Y. Shing, G. A. Soff, N. Bouck, and M. S. Pepper. 1998. Multiple forms of angiostatin induces apoptosis in endothelial cells. Blood 92:4730-4741.